Raymond James & Associates’s Colony Capital, Inc. CLNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-839,808
Closed -$17M 3490
2016
Q4
$17M Buy
839,808
+40,682
+5% +$797K 0.04% 432
2016
Q3
$14.6M Buy
799,126
+442,471
+124% +$7.83M 0.04% 452
2016
Q2
$5.47M Buy
356,655
+41,834
+13% +$727K 0.02% 806
2016
Q1
$5.28M Sell
314,821
-17,428
-5% -$293K 0.02% 791
2015
Q4
$6.47M Buy
332,249
+34,922
+12% +$711K 0.02% 692
2015
Q3
$5.82M Buy
297,327
+63,696
+27% +$1.41M 0.02% 668
2015
Q2
$5.29M Buy
233,631
+73,071
+46% +$1.86M 0.02% 787
2015
Q1
$4.16M Buy
160,560
+20,834
+15% +$522K 0.02% 843
2014
Q4
$3.33M Buy
139,726
+38,488
+38% +$896K 0.02% 886
2014
Q3
$2.27M Buy
101,238
+11,042
+12% +$249K 0.01% 1036
2014
Q2
$2.09M Buy
90,196
+10,171
+13% +$223K 0.01% 1069
2014
Q1
$1.76M Buy
80,025
+65,533
+452% +$1.44M 0.01% 1109
2013
Q4
$294K Sell
14,492
-87,998
-86% -$1.77M ﹤0.01% 1857
2013
Q3
$2.05M Buy
102,490
+31,260
+44% +$632K 0.02% 873
2013
Q2
$1.42M Buy
+71,230
New +$1.55M 0.01% 989

Other funds holding CLNY

Raymond James & Associates's CLNY Position: Q1 2017 in Review

Raymond James & Associates sold out of Colony Capital, Inc. (CLNY) in Q1 2017, closing a stake of 839,808 shares — an estimated $17M sold.

Raymond James & Associates first reported a position in CLNY in Q2 2013 and held it in 15 quarters. The position peaked at $17M in Q4 2016. 2 funds tracked by Wall St. Rank hold CLNY as of Q1 2017.

  • Raymond James & Associates reported no remaining Colony Capital, Inc. position as of Q1 2017 after selling out during the quarter.
  • Raymond James & Associates sold 839,808 Colony Capital, Inc. shares in Q1 2017, an estimated $17M.
  • Raymond James & Associates first reported a position in Colony Capital, Inc. in Q2 2013 and held it in 15 quarters.
  • Raymond James & Associates's Colony Capital, Inc. position peaked at $17M in Q4 2016.
  • 2 funds tracked by Wall St. Rank held Colony Capital, Inc. as of Q1 2017.

Based on Raymond James & Associates's 13F filing for Q1 2017, filed 15 May 2017.